Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in Narcolepsy

Mise à jour : Il y a 4 ans
Référence : NCT02348593

Femme et Homme

Extrait

This trial is a 12-week, randomized, double-blind, placebo controlled, multicenter, 4-treatment parallel group study of the safety and efficacy of JZP-110 in the treatment of excessive sleepiness in adult subjects with narcolepsy.


Critère d'inclusion

  • Narcolepsy


Liens